Proteomics

Dataset Information

0

Integrated proteomics-based physical and functional mapping of AXL kinase signaling pathways and inhibitors define its role in cell migration: ABPP


ABSTRACT: To better understand the signaling complexity of AXL, a member of the TAM family of receptor tyrosine kinases, we created a physical and functional map of AXL signaling interactions, phosphorylation events, and target-engagement of three AXL tyrosine kinase inhibitors (TKI). We assessed AXL protein-complexes using BioID, effects of AXL TKI on global phosphoproteins using mass spectrometry, and target engagement of AXL TKI using activity-based protein profiling. BioID identifies AXL-interacting proteins that are mostly involved in cell adhesion/migration. Global phosphoproteomics reveal that AXL inhibition deregulates phosphorylation of peptides involved in phosphatidylinositol-mediated signaling and cell adhesion/migration. Comparison of three AXL inhibitors reveals that TKI RXDX-106 inhibits pAXL, pAKT and migration/invasion of these cells without reducing their viability, while Bemcentinib exerts AXL-independent phenotypic effects. Proteomic characterization of these TKIs reveals that they inhibit diverse targets in addition to AXL, with Bemcentinib having the most off-targets. AXL and EGFR TKI co-treatment did not reverse resistance in cell line models of Erlotinib resistance. However, a unique vulnerability was identified in one persister clone, wherein combination of Bemcentinib and Erlotinib inhibited cell viability and signaling. We also show that AXL is overexpressed in ~30-40% of NSCLC but rarely in SCLC. NSCLC cells have a wide range of AXL protein expression, with basal activation detected rarely. Overall, we evaluate the mechanisms of action of AXL in lung cancer which can be used to establish assays to measure drug targetable active AXL complexes in patient tissues and inform the strategy for targeting its signaling network as an anticancer therapy.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Lung Epithelium

DISEASE(S): Lung Adenocarcinoma

SUBMITTER: John Koomen  

LAB HEAD: Eric B. Haura, MD

PROVIDER: PXD023913 | Pride | 2022-10-14

REPOSITORIES: pride

altmetric image

Publications

Integrated Proteomics-Based Physical and Functional Mapping of AXL Kinase Signaling Pathways and Inhibitors Define Its Role in Cell Migration.

Majumder Anurima A   Hosseinian Sina S   Stroud Mia M   Adhikari Emma E   Saller James J JJ   Smith Matthew A MA   Zhang Guolin G   Agarwal Shruti S   Creixell Marc M   Meyer Benjamin S BS   Kinose Fumi F   Bowers Kiah K   Fang Bin B   Stewart Paul A PA   Welsh Eric A EA   Boyle Theresa A TA   Meyer Aaron S AS   Koomen John M JM   Haura Eric B EB  

Molecular cancer research : MCR 20220401 4


To better understand the signaling complexity of AXL, a member of the tumor-associated macrophage (TAM) receptor tyrosine kinase family, we created a physical and functional map of AXL signaling interactions, phosphorylation events, and target-engagement of three AXL tyrosine kinase inhibitors (TKI). We assessed AXL protein complexes using proximity-dependent biotinylation (BioID), effects of AXL TKI on global phosphoproteins using mass spectrometry, and target engagement of AXL TKI using activi  ...[more]

Similar Datasets

2022-10-14 | PXD023923 | Pride
2022-10-14 | PXD023911 | Pride
2013-08-10 | E-GEOD-49135 | biostudies-arrayexpress
2022-04-13 | GSE191185 | GEO
2019-10-25 | E-MTAB-8294 | biostudies-arrayexpress
2013-08-10 | GSE49135 | GEO
2021-07-08 | PXD011803 | Pride
2019-03-01 | GSE123674 | GEO
2012-05-29 | E-GEOD-38310 | biostudies-arrayexpress
2019-01-01 | GSE106151 | GEO